The burden of cancer is rising globally and is estimated to have reached 18.1 million new cases and 9.6 million cancer deaths in 2018. Despite the rising cancer incidence, improvements in early detection and therapeutic treatment have improved cancer survival. Therefore, the number of cancer survivors is increasing globally, creating the need to improve not only treatment but also wellness and follow-up care. 
Cancer treatment often involves combined modalities such as surgery, chemotherapy, and radiotherapy. In the past decades, more effective and targeted therapeutic modalities and less destructive cancer treatments have been developed such as immunotherapy and drug-targeted therapy. Even so, cancer and its treatment have important physical and psychosocial sequelae. 

In ONCORELIEF we leverage the above-mentioned key drivers to overcome technical challenges skilfully and methodologically, by introducing new approaches that allow the utilization of big datasets. We develop a user-centered AI System to facilitate the integration of QoL assessment instruments using PROMs and PREMs to improve post-treatment health status, increase the wellbeing, and follow-up care of cancer patients. 

This was achieved through an intuitive smart digital assistant (Guardian Angel), able to provide personalized support in post-treatment activities and tasks, suggest actions regarding the patients' overall health-status, improved wellbeing and active healthcare and ultimately maintain them engaged on a wellness journey that safeguards their health over the foreseeable prolonged post-cancer treatment period. To achieve this, ONCORELIEF builds on the combined knowhow of its interdisciplinary industry-driven consortium that brings together state-of-the-art technological skills, design thinking methodology and occupational psychology/health sciences.